Bridgebio Oncology Therapeutics Inc.
09/10/2025 | Press release | Distributed by Public on 09/11/2025 04:03
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 10, 2025 4:01 P.M. |
| Form: | S-1 | ||||||
|
|||||||
Bridgebio Oncology Therapeutics Inc. published this content on September 10, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on September 11, 2025 at 10:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]